Tara Brah, MD
Obstetrics/Gynecology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 10 years
- Graduated 2016
Offices
4 locations · Community Foundation Medical Group · 282 clinicians in this group
Looking this up.
Hospitals listed: Community Regional Medical Center · Fresno Surgical Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brah’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Fresno Surgical HospitalFresno, CAAcute Care Hospital · Proprietary · No emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 4 of 5 · 84% would definitely recommend itNo overall ratingBetter than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 1,007 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Fresno Surgical Hospital
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 1 better, 2 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 1,007 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.35 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.8 · 439 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 934 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 918 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.75 (0.56 to 4.94) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.67 to 3.88) · 915 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.35 (0 to 13.68) · 929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.95 (0.18 to 7.73) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 390 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.9) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 135 cases | None | Apr 2023 – Mar 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 129 cases | None | Jul 2023 – Jun 2025 |
What patients said (405 patients answered, 45% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 85% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$57,434
Medicare paid this office $57,434 for 234 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 178 | $21,497 | $100 |
| Biopsy of lining of uterus and/or removal of polyp using an endoscope | 16 | $17,457 | $1,091 |
| New patient visit (45+ min) | 24 | $2,876 | $120 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 156 | $2,186 | $13 |
| New patient visit (60+ min) | 13 | $2,143 | $165 |
See all 10 services
| Return visit (30+ min) | 178 | $21,497 | $100 |
| Biopsy of lining of uterus and/or removal of polyp using an endoscope | 16 | $17,457 | $1,091 |
| New patient visit (45+ min) | 24 | $2,876 | $120 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 156 | $2,186 | $13 |
| New patient visit (60+ min) | 13 | $2,143 | $165 |
| Pelvic exam | 91 | $1,852 | $19 |
| Insertion of temporary bladder tube | 39 | $1,485 | $36 |
| Short return visit (20+ min) | 23 | $1,327 | $55 |
| Ultrasound measurement of bladder capacity after voiding | 76 | $779 | $9 |
| Automated urinalysis test | 169 | $431 | $2 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | – | – | – | 83 |
| Insertion of temporary bladder tube | – | – | – | 41 |
| Biopsy of lining of uterus and/or removal of polyp using an endoscope | – | – | 12 | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
234 Original Medicare patients in 2024. Average age 75 · Women 100% · Also on Medicaid 14% · Health risk score 0.93. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 75% · Coronary heart disease 33% · Diabetes 26% · Chronic kidney disease 22% · Depression 21% · Atrial fibrillation 13% · Heart failure 12% · Cancer 10% · COPD 9% · Stroke 6%.
The office billed $286,123, Medicare allowed $73,652 and paid $57,434; for 943 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 234 | 943 | 75 | 0.93 | $286,123 | $57,434 |
| 2023 | 67 | 150 | 73 | 0.99 | $152,405 | $29,804 |
| 2022 | 32 | 54 | 69 | 1.36 | $40,527 | $7,865 |
| 2021 | 16 | 29 | 62 | 1.17 | $15,874 | $3,259 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Biopsy of lining of uterus and/or removal of polyp using an endoscope | 12 | $13,991 | $1,166 |
| Return visit (30+ min) | 39 | $4,592 | $100 |
| New patient visit (45+ min) | 13 | $1,652 | $127 |
2022: 1 service
| Return visit (30+ min) | 12 | $1,193 | $99 |
Drugs they prescribed that Part D paid
$7,485
Pharmacies billed $7,485 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
44 generic and 20 brand-name prescriptions · $7,485 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Imvexxy | 12 | $5,140 | $428 |
| Estradiol | 11 | $381 | $35 |
Year by year
| 2024 | 64 | 29 | None | 31% | $7,485 |
| 2023 | 52 | 23 | None | None | $1,690 |
| 2022 | 63 | 22 | None | None | $3,186 |
| 2021 | 31 | None | None | None | $1,565 |
| 2020 | 20 | None | None | 0% | $571 |
| 2019 | 11 | None | None | 0% | $85 |
| 2018 | 14 | None | None | 0% | $103 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Norethindrone Acetate | 16 | $1,124 | $70 |
Money from drug and device companies
$147 in 2025
| 2025 | 5 | 6 | None | $147 |
| 2024 | 10 | 53 | None | $2,426 |
| 2023 | 8 | 71 | None | $1,467 |
| 2022 | 3 | 6 | None | $1,103 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $52 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $44 | 2 payments
|
| Dentsply Ih Ab | Lofric | $24 | 1 payment
|
| Meditrina | None | $19 | 1 payment
|
| Mayne Pharma Commercial | None | $8 | 1 payment
|
See all 6 published payments
| Sumitomo Pharma America | Meals · 2025-10-22 | Gemtesa | $20 |
| Mayne Pharma Commercial | Meals · 2025-09-17 | None | $8 |
| Dentsply Ih Ab | Meals · 2025-09-11 | Lofric | $24 |
| Sumitomo Pharma America | Meals · 2025-07-17 | Gemtesa | $24 |
| Stryker | Meals · 2025-03-13 | Mako | $52 |
| Meditrina | Meals · 2025-01-22 | None | $19 |
See earlier years (2024, 2023, 2022)
2024: $2,426
| Medical Device Business Services | Harmonic | $1,149 | 5 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $550 | 5 payments
|
| Sumitomo Pharma America | Gemtesa | $319 | 33 payments
|
| Ethicon US | Stratafix | $210 | 3 payments
|
| Boston Scientific | Upsylon | $96 | 2 payments
|
| Mayne Pharma Commercial | None | $28 | 1 payment
|
| MIMEDX Group | None | $22 | 1 payment
|
| Axonics | Axonics | $18 | 1 payment
|
| KARL STORZ Endoscopy-America | Hopkins | $17 | 1 payment
|
| Laborie Medical Technologies | None | $17 | 1 payment
|
2023: $1,467
| Intuitive Surgical | Da Vinci Surgical System | $805 | 6 payments
|
| Sumitomo Pharma America | Gemtesa | $462 | 56 payments
|
| Astellas Pharma US | Myrbetriq | $58 | 3 payments
|
| AbbVie | Liletta | $52 | 2 payments
|
| Boston Scientific | Upsylon | $37 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $20 | 1 payment
|
| Pfizer | Myfembree | $19 | 1 payment
|
| Hologic Sales and Service | Myosure Tissue Removal Device | $13 | 1 payment
|
2022: $1,103
| Intuitive Surgical | Davinci Xi | $1,029 | 2 payments
|
| Urovant Sciences | Gemtesa | $51 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1558724286
- Licence
- MD D89259
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 6201 Greenleigh Ave, Middle River, MD, 21220
- NPI first listed
- 2016-03-31
- NPI last updated
- 2021-05-21
- NPI record certified
- 2021-05-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 155 N Fresno St, Fresno, CA, 93701